HomeTobramycin Inhalation SolutionTobramycin Inhalation Solution + Mannitol

Does Tobramycin Inhalation Solution Interact with Mannitol?

Tobramycin Inhalation Solution and Mannitol have a contraindicated drug interaction according to U.S. FDA drug labeling data. Intravenous mannitol should not be administered concomitantly; diuretics can enhance aminoglycoside toxicity by altering antibiotic concentrations in serum and tissue. The mechanism involves enhanced aminoglycoside toxicity through altered serum and tissue antibiotic concentrations. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Contraindicated
Tobramycin Inhalation Solution Class
Aminoglycoside Antibacterial
Mannitol Class
Osmotic Diuretic
Management
Do not take together
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Tobramycin Inhalation Solution and Mannitol occurs because enhanced aminoglycoside toxicity through altered serum and tissue antibiotic concentrations. Clinically, this means intravenous mannitol should not be administered concomitantly; diuretics can enhance aminoglycoside toxicity by altering antibiotic concentrations in serum and tissue. Because of the severity of this interaction, these medications are contraindicated — meaning they should not be taken together under any circumstances. If you are currently taking both, contact your healthcare provider immediately to discuss alternatives.

What To Tell Your Doctor or Pharmacist

If you are taking Tobramycin Inhalation Solution and your doctor is considering prescribing Mannitol (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask about alternative medications that do not interact with your current regimen
  • Ask how frequently you should be monitored while these are co-prescribed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Tobramycin Inhalation Solution(Bethkis)+💊 Mannitol(Osmitrol)

Severity & Interaction Details

contraindicated
Avoid this combination
FDA labeling lists this pair as contraindicated. The risk outweighs the benefit in nearly all cases.
Severity scale
MinorContra
On record
Yes
Drug A class
Aminoglycoside Antibacterial
Drug B class
Osmotic Diuretic
Source
NLP:tobramycin inhalation

What this means in plain English

Intravenous mannitol should not be administered concomitantly; diuretics can enhance aminoglycoside toxicity by altering antibiotic concentrations in serum and tissue.

About Tobramycin Inhalation Solution and Mannitol

Tobramycin Inhalation Solution is an Aminoglycoside Antibacterial, while Mannitol is an Osmotic Diuretic. You may recognize them by the brand names Bethkis and Osmitrol. Tobramycin Inhalation Solution is inhaled, whereas Mannitol is given by intravenous (IV) infusion. Mannitol additionally carries an FDA boxed warning, the FDA's strongest safety alert.

What the FDA label says

"Enhanced aminoglycoside toxicity through altered serum and tissue antibiotic concentrations"

📖 Source: NLP:tobramycin inhalation

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Tobramycin Inhalation Solution and Mannitol against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.